Literature DB >> 4014731

Incidence of malignant hyperthermia in Denmark.

H Ording.   

Abstract

Questionnaires were sent to all anesthesia departments in Denmark to determine the total number of anesthetics given per year, and the distribution of different types of anesthesia. All cases of suspected malignant hyperthermia forwarded to the Danish Malignant Hyperthermia Register during a 6.5 yr period were reviewed and divided into subgroups according to clinical criteria. The incidence of suspected malignant hyperthermia in these subgroups was calculated in relation to type of anesthesia. The results are based on information about 386,250 anesthetics and 154 cases of suspected malignant hyperthermia. All cases of malignant hyperthermia occurred during general anesthesia, and more than 75% during anesthesia with a combination of potent inhalation agents and succinylcholine. The incidence of fulminant malignant hyperthermia was low: 1 in 250,000 total anesthetic procedures, but 1 in 62,000 anesthetic procedures with a combination of potent inhalation agents and succinylcholine. Masseter spasm occurred in 1 of 12,000 anesthetic procedures in which succinylcholine was administered. Suspicion of malignant hyperthermia was raised in 1 of 16,000 anesthetics total, but in 1 of 4,200 anesthetics with the above-mentioned combination of agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4014731

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  28 in total

1.  The importance of calcium ions for in vitro malignant hyperthermia testing.

Authors:  J E Fletcher; F J Huggins; H Rosenberg
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

2.  Atracurium and succinylcholine on the masseter muscle.

Authors:  B W Brandom
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

3.  Clinical utility gene card for: malignant hyperthermia.

Authors:  Henry Rosenberg; Henrik Rueffert
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

Review 4.  [Malignant hyperthermia].

Authors:  T Metterlein; F Schuster; B M Graf; M Anetseder
Journal:  Anaesthesist       Date:  2014-12       Impact factor: 1.041

5.  Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.

Authors:  Jerry H Kim; Gail P Jarvik; Brian L Browning; Ramakrishnan Rajagopalan; Adam S Gordon; Mark J Rieder; Peggy D Robertson; Deborah A Nickerson; Nickla A Fisher; Philip M Hopkins
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

6.  [Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].

Authors:  B Petersen; T Busch; C-D Meinecke; B Börge; K Kluba; U X Kaisers; H Rüffert
Journal:  Anaesthesist       Date:  2015-10-19       Impact factor: 1.041

Review 7.  Special article: Future directions in malignant hyperthermia research and patient care.

Authors:  Sharon J Hirshey Dirksen; Marilyn Green Larach; Henry Rosenberg; Barbara W Brandom; Jerome Parness; Robert Scott Lang; Meera Gangadharan; Tyler Pezalski
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

8.  Amide local anaesthetics and malignant hyperthermia.

Authors:  R T Paasuke; A K Brownell
Journal:  Can Anaesth Soc J       Date:  1986-03

9.  Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.

Authors:  Yuri Hosokawa; Douglas J Casa; Henry Rosenberg; John F Capacchione; Emmanuel Sagui; Sheila Riazi; Luke N Belval; Patricia A Deuster; John F Jardine; Stavros A Kavouras; Elaine C Lee; Kevin C Miller; Sheila M Muldoon; Francis G O'Connor; Scott R Sailor; Nyamkhishig Sambuughin; Rebecca L Stearns; William M Adams; Robert A Huggins; Lesley W Vandermark
Journal:  J Athl Train       Date:  2017-03-07       Impact factor: 2.860

10.  Malignant hyperthermia susceptibility in adult patients with masseter muscle rigidity.

Authors:  G C Allen; H Rosenberg
Journal:  Can J Anaesth       Date:  1990-01       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.